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1. Introduction 
The presence of sialic acid in the cell surface 
glycoconjugates has a crucial importance in a variety 
of biological cell properties. It has been involved in 
the electrokinetic potential of the cell [l] and in the 
permeability of the membrane [2]. More recently, it 
has been related to the social life of the cell: cell-cell 
recognition [3], contact inhibition [4] and crypticity 
of immunogenic loci [5] . Moreover, changes in 
membrane-bound sialic acid have been reported to 
occur upon oncogenic transformation [6]. Further- 
more, the sialic acid level at the cell surface seems to 
be correlated to the life-time of the cell [7] and to 
regulate the activity of some ecto-enzymes [8]. 
These facts raise the question as to how the surface 
sialic acid level is maintained or modulated: does it 
need an intracellular biosynthesis of the complete 
glycoconjugates and their further integration in the 
membrane or may it be due to the activity of an 
ectosialyltransferase as a repair phenomenon? In fact, 
ectosialyltransferase activity has been widely reported 
[9-121 and ultrastructural evidence has been obtained 
[13] . In this paper, we demonstrate that rat spleen 
lymphocyte possesses an ectosialyltransferase which 
is able to transfer N-acetylneuraminic acid to its own 
membrane but is not able to transfer it to a macro- 
molecular exogenous acceptor. However, when the 
size of the same exogenous acceptor is reduced by 
proteolytic cleavage, it can reach the active site of the 
ecto-enzyme and is efficiently glycosylated. 
2. Materials and methods 
2.1. Preparation of cells, crude homogenate and 
microsomal fractions 
Spleen lymphocytes were prepared from three 
month old Sprague-Dawley rats as previously described 
[ 141. Lymphocyte suspension was homogenized in a 
Potter-Elvejhem apparatus (3 X 10 strokes at 1250 
rev./min). The homogenate was centrifuged at 
15 000 X g for 20 min and the resulting supernatant 
was used for preparation of microsomal fractions by 
centrifugation (150 000 X g for 90 min). The acceptor 
capacity of the various asialoglycoproteins was also 
tested with rat liver microsomal fractions prepared 
according to the same procedure. 
2.2. Preparation of macromolecular acceptors 
Orosomucoid (or -acid glycoprotein) was isolated 
from pooled human serum by the procedure of 
Schmid et al. [ 151. Glycophorin was extracted from 
ORh’human erythrocyte ghosts as described by 
Marchesi and Andrews [ 161 . Orosomucoid and glyco- 
phorin were desialylated by mild hydrolysis (0.01 N 
HzS04, lOO”C, 30 min). Effective desialylation was 
checked by gas-liquid chromatography analysis. 
Coupling of acceptors to Sepharose 4 B beads was 
achieved as previously described [ 141. 
2.3. Preparation of micromolecular acceptor 
Asialoglycophorin was subjected to extensive 
pronase (Calbiochem) digestion (1 mg for 50 mg of 
234 North-Holland Publishing Company - Amsterdam 
Volume 74, number 2 FEBS LETTERS March 1977 
asialoglycoprotein, during 72 h at 37°C). A low 
molecular weight glycopeptide has been purified by 
chromatography on Biogel P-6 column [ 171. Its 
molecular weight has been estimated to around 1500 
according to its distribution coefficient, its carbo- 
hydrate molar composition is GaWAc : Gal (1 : 1) as 
determined by gas-liquid chromatography. 
2.4. Sialyltransferase assays 
The incubation mixture contained 0.1 M sodium 
cacodylate pH 7.4,O. 154 M NaCl, 5 mM MnClz and 
0.2 /&/ml of [‘“Cl NANA-CMP (Amersham, spec. 
act. 214 mCi/mM). Standard assays (100 ~1) contained 
2 X 10’ cells and 1 mg of acceptors. Incubation was 
achieved at 30°C under a constant slow rotation, for 
1 h. 
2.5. Separation of cell from acceptors and determina- 
tion of radioactivity 
Macromolecular or Sepharose-bound acceptors 
were separated from cells as described previously [ 141. 
When micromolecular acceptor was used, the super- 
natant after the cell sedimentation was spotted on 
Whatman 3 paper and submitted to chromatography 
in the following solvent: ethyl acetate/pyridine/glacial 
acetic acid/water (5 : 5 : 1 : 3). The acceptor-bound 
radioactive sialic acid remained near the origin free of 
precursor ( [r4C]NANA-CMP) and of degradation 
products ( [r4C]NANA) which had migrated. The 
radioactivity of the material was determined by 
counting in scintillation liquid. 
3. Results and discussion 
3.1. Kinetic studies of ectosialyltransferase activity 
with macromolecular accep tars 
As we previously demonstrated, the use of an 
insolubilized acceptor is a good approach to detect 
ectogalactosyltransferase on intact lymphocytes 
[ 141, we devised the same experiments for ectosialyl- 
transferase. Incubation of lymphocytes with asialo- 
orosomucoid coupled beads and [ 14C] NANA-CMP 
reveals that incorporation of radioactivity is restricted 
to the cells. The non-incorporation on an insolubilized 
acceptor could be due to an alteration of acceptor 
sites by the chemical treatment for coupling. In fact, 
fig.1 a shows a kinetic study using soluble asialo- 
Incubation time (min) 
F&l.(a) Kinetic study of the incorporation of radioactive 
sialic acid on lymphocytes (o-o) and on soluble asialo- 
orosomucoid (o----o). (b) Kinetic study of the NANA-CMP 
integrity (o-o) and free NANA appearance (o-o). 
orosomucoid. Again, no significant radioactivity is 
bound to the acceptor compared to the radioactivity 
recovered with the cells. This fact has been noticed 
by Patt and Grimes with tibroblasts [ 181. As 
described for rat liver plasma membrane [ 191, whole 
lymphocyte exhibits a NANA-CMP hydrolase 
activity, which contributes to the formation of free 
sialic acid in the medium (fig.1 b). As sialic acid may 
enter the cell [20] we checked that a IOOO-fold 
excess of unlabelled sialic acid does not reduce signifi- 
cantly (less than 10%) the radioactivity of the cells. 
This indicates that entry of [ 14C]NANA cannot 
explain the labelling of the cells. 
3.2. Influence of the cell concentration 
As the standard assay contained 2 X 10 cells/ml 
it was worth examining if higher concentration of cells, 
i.e., of enzyme, could lead to a sialylation at a higher 
level of the exogenous acceptor. Figure 2 reveals that, 
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Fig.2.(a) Effect of cell concentration on the incorporation of 
radioactive sialic acid on the cells (o-o) and on soluble 
asialo-orosomucoid (0-e). (b) Effect of cell concentration 
on NANA-CMP integrity (o-o) and free NANA appearance 
(e-e). Logarithmic scale is used to represent the cell 
concentration. 
at any concentration, the cells are not able to catalyze 
the transfer on a macromolecular acceptor although a 
cell concentration-dependency is noted for the cell 
surface sialylation. In addition this shows that, if 
significant, [r4C]NANA incorporation on the exo- 
genous acceptor does not behave as the endogenous 
membrane acceptors. 
3.3. Comparison between sialylation of macro- and 
micromolecular acceptors 
Non-incorporation of sialyl residues on asialo- 
orosomucoid could be due to the inability of this 
acceptor to form the enzyme-substrate complex with 
the lymphocyte ectosialyltransferase. To test this 
possibility we used two other acceptors: 
(i) Native ovomucoid which is a poor sialyl acceptor 
(one terminal galactosyl residue per glycan moiety 
3 a 
Fig.3. Relative incorporation of various macromolecular and 
micromolecular acceptors with (a) whole cells and (b) micro- 
somal fraction. The various acceptors are as follows: (1) 
asialo-orosomucoid, (2) ovomucoid, (3) asialoglycophorin, 
(4) glycopeptidic acceptor. Acceptors have been used at a final 
concentration of 10 mg/ml except for the micromolecular 
(glycopeptidic) acceptor for which the dilution (8 mg/ml) 
has been done to obtain the 1 : 1 ratio of incorporation as 
compared to asialoglycophorin when assayed with microsomal 
fraction. 
[21]) but which has been a suitable acceptor in the 
lymphocyte system [ 141. 
(ii) Asialoglycophorin whose very good acceptor 
capacity is due to its high content of sialyl residues 
in the native form, moreover is a membrane glyco- 
protein. 
As asialo-orosomucoid, these two asialoglyco- 
proteins cannot be significantly sialylated by intact 
lymphocytes (tig.3a) however, they appeared as good 
acceptors of sialyl residues when assayed with micro- 
somal sialyltransferase (fig.3b). 
Thus it raises the question as to whether this 
peculiar property may be related to the fact that a 
macromolecular exogenous acceptor cannot reach the 
active site of the ecto-enzyme. To answer this question, 
ectosialyltransferase has been tested with a small 
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glycopeptide obtained after extensive pronase diges- 
tion of the asialoglycophorin. Figure 3a shows that 
this micromolecular acceptor may be highly sialylated 
by the ectosialyltransferase if compared to the sialyla- 
tion of the originating macromolecule. When the 
acceptor capacity is equal for macromolecular and 
micromolecular acceptor in a microsomal system, the 
sialylation of the macromolecular acceptor decreases 
in a large extent (more than 5-times) with intact cell 
system (95% viability). 
3.4. Additional proof of this peculiar ectosialyl- 
transferase activity 
The peculiar properties of the enzymic activity 
detected with whole cells favored the existence of an 
ectosialyltransferase. However, on the one hand, 
phagocytosis of acceptors and further intracellular 
glycosylation may not be excluded. On the other 
hand, whole cell preparations contain from l-10% 
broken cells which could be responsible for the 
detected sialyltransferase activity. To demonstrate 
clearly the involvement of an ecto-enzyme we devised 
the experiments recommended by Lennarz [22]. 
Figure 4 shows that as the proportion of broken cells 
is increased, incorporation of sialyl residues on 
asialo-orosomucoid and micromolecular acceptor 
4 
percent of broken cells 
Fig.4. Sialic acid incorporation as a function of the percentage 
of broken cells present in an incubation, on the soluble asialo- 
orosomucoid (o-0) and on the glycopeptidic micromolecular 
acceptor (A-A). Mixture of known proportion of intact and 
broken cells were added to the incubation medium. In this 
experiment 90% of the stock suspension of cells excluded 
Trypan Blue (arrow). 
increases. More important is the fact that extrapola- 
tion to 100% intact cells indicates significant incorpo- 
ration on the micromolecular acceptor but no incor- 
poration on the macromolecular acceptor. Thus, the 
intracellular enzyme may be monitored by the sialyla- 
tion of asialo-orosomucoid and the low level of [14C] 
NANA transfer on macromolecular acceptors, 
observed with whole cell incubations, is due to the 
low proportion of broken cells. Macromolecular 
acceptor sialylation inability appears to be a peculiar 
property of the lymphocyte ectosialyltransferase. 
4. Conclusion 
Demonstration ectoglycosyltransferase occurrence 
requires three main criteria [23 ] : 
(i) No entry of free carbohydrate into the cell if 
precursor hydrolysis occurs 
(ii) No release or secretion of intracellular enzymes, 
(iii) No phagocytosis of acceptors. 
Cell-labeling obtained with [14C]NANA-CMP in 
the presence of excess unlabelled NANA allows us to 
exclude the first cause of error. Secondly, as transfer 
on macromolecular acceptor is not observed with 
intact cells it is rather difficult to consider that 
phagocytosis and further release of the sialylated 
product may occur. Finally, experiments with increas- 
ing proportion of broken cells allow us to determine 
that the.depicted transferase activity is really due to 
an ectosialyltransferase. This peculiar property of the 
ecto-enzyme to transfer sialic acid on micromolecular 
acceptor or on the nearby membranous acceptors, 
strongly suggests that it is a rather buried ‘intrinsic’ 
membrane enzyme. This enzyme would be more 
concerned with the sialylation of surrounding mem- 
branous acceptors in a ‘cis-glycosylation’ process. 
This role in repairing the cell surface glycoconjugates 
is in a good accordance with observations of Harms 
and Reutter [24] showing that membrane sialic acid 
has a higher turnover rate than the membrane proteins. 
This sialic acid renewal appears to be crucial for many 
biological properties of the cell. 
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